Success Metrics

Clinical Success Rate
93.8%

Based on 15 completed trials

Completion Rate
94%(15/16)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_4
7
44%
Ph phase_3
8
50%
Ph phase_2
1
6%

Phase Distribution

0

Early Stage

1

Mid Stage

15

Late Stage

Phase Distribution16 total trials
Phase 2Efficacy & side effects
1(6.3%)
Phase 3Large-scale testing
8(50.0%)
Phase 4Post-market surveillance
7(43.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.8%

15 of 16 finished

Non-Completion Rate

6.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Completed(15)
Terminated(1)

Detailed Status

Completed15
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
93.8%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (6.3%)
Phase 38 (50.0%)
Phase 47 (43.8%)

Trials by Status

terminated16%
completed1594%

Recent Activity

0 active trials
Showing 5 of 16
completedphase_4

Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib

NCT00348491
completedphase_4

Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension

NCT00267176
terminatedphase_2

Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia

NCT01481610
completedphase_3

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA)

NCT00475800
completedphase_3

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)

NCT00367315
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT00348491Phase 4

Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib

Completed
NCT00267176Phase 4

Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension

Completed
NCT01481610Phase 2

Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia

Terminated
NCT00475800Phase 3

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA)

Completed
NCT00367315Phase 3

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)

Completed
NCT00476034Phase 3

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)

Completed
NCT00267215Phase 3

Efficacy and Safety of Lumiracoxib

Completed
NCT00145301Phase 3

52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine

Completed
NCT00366938Phase 3

Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA).

Completed
NCT00170872Phase 3

6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis

Completed
NCT00637949Phase 3

Safety of Lumiracoxib in Patients With Osteoarthritis

Completed
NCT00333567Phase 4

Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery

Completed
NCT00350155Phase 4

Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel

Completed
NCT00419796Phase 4

Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension

Completed
NCT00170781Phase 4

Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout

Completed
NCT00170898Phase 4

Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16